Author Question: A patient with atrial flutter is admitted to the unit and remains in atrial flutter for 24 hours. ... (Read 79 times)

HudsonKB16

  • Hero Member
  • *****
  • Posts: 535
A patient with atrial flutter is admitted to the unit and remains in atrial flutter for 24 hours. Which drug does the nurse anticipate will be given to attempt conversion to sinus rhythm?
 
  a. Ibutilide (Covert)
  b. Warfarin (Coumadin)
  c. Verapamil (Calan)
  d. Diltiazem (Cardizem)

Question 2

The nurse is caring for a patient who has been taking amiodarone (Cordarone) for several months. The patient begins to exhibit dyspnea and coughing and complains of chest pain. The nurse is correct to suspect
 
  a. cardiovascular toxicity.
  b. pulmonary toxicity.
  c. heart failure.
  d. an impending myocardial infarction.



mcarey591

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

ANS: A
Ibutilide (Covert) is the drug of choice for pharmacologic conversion from atrial flutter to sinus rhythm.
If the patient stayed in atrial flutter, warfarin would be instituted to reduce the risk of stroke.
Verapamil and diltiazem might be given to control the ventricular rate if the patient remained in atrial flutter.

Answer to Question 2

ANS: B
Lung damage is the most serious adverse effect of amiodarone (Cordarone).
Cardiovascular toxicity is evidenced by a paradoxical increase in dysrhythmic activity.
The patient's symptoms (dyspnea, cough, chest pain) are similar to those of heart failure and pneumonia; however, these symptoms are associated with the prolongation of amiodarone in the system.
No evidence indicates an impending MI.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

For a complete list of videos, visit our video library